Janney Montgomery Scott’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.36M | Sell |
13,023
-1,900
| -13% | -$198K | ﹤0.01% | 1406 |
|
2025
Q1 | $1.74M | Buy |
14,923
+1,178
| +9% | +$137K | ﹤0.01% | 1223 |
|
2024
Q4 | $1.16M | Buy |
13,745
+6,546
| +91% | +$554K | ﹤0.01% | 1454 |
|
2024
Q3 | $647K | Buy |
7,199
+1,569
| +28% | +$141K | ﹤0.01% | 1787 |
|
2024
Q2 | $453K | Sell |
5,630
-150
| -3% | -$12.1K | ﹤0.01% | 1962 |
|
2024
Q1 | $461K | Buy |
5,780
+500
| +9% | +$39.9K | ﹤0.01% | 2063 |
|
2023
Q4 | $420K | Sell |
5,280
-280
| -5% | -$22.3K | ﹤0.01% | 2024 |
|
2023
Q3 | $389K | Buy |
5,560
+1,073
| +24% | +$75.1K | ﹤0.01% | 1962 |
|
2023
Q2 | $322K | Buy |
+4,487
| New | +$322K | ﹤0.01% | 2181 |
|
2023
Q1 | – | Sell |
-2,805
| Closed | -$216K | – | 2527 |
|
2022
Q4 | $216K | Buy |
+2,805
| New | +$216K | ﹤0.01% | 2327 |
|
2022
Q2 | – | Sell |
-5,722
| Closed | -$237K | – | 2315 |
|
2022
Q1 | $237K | Sell |
5,722
-327
| -5% | -$13.5K | ﹤0.01% | 1999 |
|
2021
Q4 | $229K | Buy |
+6,049
| New | +$229K | ﹤0.01% | 2161 |
|
2021
Q3 | – | Sell |
-10,540
| Closed | -$711K | – | 2287 |
|
2021
Q2 | $711K | Buy |
10,540
+500
| +5% | +$33.7K | ﹤0.01% | 1443 |
|
2021
Q1 | $568K | Buy |
10,040
+85
| +0.9% | +$4.81K | ﹤0.01% | 1484 |
|
2020
Q4 | $811K | Buy |
9,955
+312
| +3% | +$25.4K | ﹤0.01% | 1284 |
|
2020
Q3 | $687K | Sell |
9,643
-1,129
| -10% | -$80.4K | ﹤0.01% | 1270 |
|
2020
Q2 | $886K | Buy |
10,772
+2,416
| +29% | +$199K | 0.01% | 1084 |
|
2020
Q1 | $492K | Sell |
8,356
-14,004
| -63% | -$825K | ﹤0.01% | 1227 |
|
2019
Q4 | $2.31M | Sell |
22,360
-6,115
| -21% | -$632K | 0.02% | 741 |
|
2019
Q3 | $576K | Buy |
28,475
+950
| +3% | +$19.2K | ﹤0.01% | 1308 |
|
2019
Q2 | $709K | Buy |
27,525
+9,950
| +57% | +$256K | 0.01% | 1223 |
|
2019
Q1 | $250K | Buy |
+17,575
| New | +$250K | ﹤0.01% | 1748 |
|